Hyphens Pharma International Ltd
SGX:1J5
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Hyphens Pharma International Ltd
Net Income (Common)
Hyphens Pharma International Ltd
Net Income (Common) Peer Comparison
WVE
H02
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Net Income (Common)
S$8.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Net Income (Common)
-$61.7m
|
CAGR 3-Years
25%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Haw Par Corporation Ltd
SGX:H02
|
Net Income (Common)
S$216.6m
|
CAGR 3-Years
22%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
I
|
IX Biopharma Ltd
SGX:42C
|
Net Income (Common)
-S$9.6m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
See Also
What is Hyphens Pharma International Ltd's Net Income (Common)?
Net Income (Common)
8.6m
SGD
Based on the financial report for Dec 31, 2023, Hyphens Pharma International Ltd's Net Income (Common) amounts to 8.6m SGD.
What is Hyphens Pharma International Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
10%
Over the last year, the Net Income (Common) growth was -25%. The average annual Net Income (Common) growth rates for Hyphens Pharma International Ltd have been 12% over the past three years , 10% over the past five years .
You don't have any saved screeners yet
